GIST Surgery - Gastrointestinal Stromal Tumor Surgery

Remove the tumor whole, keep the organ. Then match the tablets to its genes.

Three years of imatinib after surgery raised five-year survival from 81.7 to 92.0 percent in patients with high-risk GIST.

What a GIST is

A GIST grows from the pacemaker cells in the muscle wall of the gut, the cells that set the rhythm of its contractions. Most begin in the stomach and about a third in the small bowel, and a few arise in the duodenum, the rectum or the esophagus. They push outward or inward from the wall instead of spreading along the lining. So they grow large before giving symptoms. They rarely reach lymph nodes. Most carry a mutation in the KIT or PDGFRA gene. Imatinib targets it.

How the risk of recurrence is judged

Surgery cures, and the pathology report decides what comes next.

Before any decision, we gather

1. a CT or MRI of the abdomen and pelvis to map the tumor and look for spread,
2. an endoscopic ultrasound for stomach, duodenal and rectal tumors,
3. a biopsy, often through the endoscope, when imatinib may be given first,
4. and the mutation test on that tissue.

Four things the pathologist reports

A pooled analysis of 2,560 patients treated with surgery alone, without imatinib, found that 59.9 percent were free of recurrence at 15 years, and few recurrences appeared after the tenth year. Large size, a high mitotic count, a site outside the stomach, rupture and male sex each raised the risk. Those factors decide what follows. Size alone is not enough.

On a phone, swipe the table sideways to read every column.

Why gene testing comes before treatment

Imatinib works well against the commonest KIT mutations and poorly or not at all against others, including the PDGFRA D842V change and the tumors that carry no KIT or PDGFRA mutation. Testing the biopsy or the removed tumor tells the team whether a tablet will help before months of it are prescribed, and it shapes the dose, since tumors with a KIT exon 9 mutation respond better to a higher one.

Which operation each site needs

The aim never changes. It is a complete removal with clear margins and an unbroken capsule. Lymph nodes are not removed routinely, because a GIST rarely spreads to them.

Scroll the table sideways on small screens.

The capsule is thin, and keeping it intact is the most important part of the operation.

What the imatinib trials showed

After surgery

In the American ACOSOG Z9001 trial, 713 patients with a tumor of at least 3 centimeters were randomized after surgery to imatinib or placebo for one year. Recurrence-free survival at one year was 98 percent with imatinib and 83 percent with placebo, and the trial was stopped early. A Scandinavian and German trial then compared one year with three years in 400 patients at high risk. Three years gave a five-year recurrence-free survival of 65.6 percent against 47.9 percent and a five-year overall survival of 92.0 percent against 81.7 percent, though 25.8 percent of patients stopped the tablets early for reasons other than recurrence, against 12.6 percent in the one-year group, because of side effects such as swelling around the eyes, fatigue, muscle cramps and diarrhea.

Swipe sideways on a narrow screen to compare both trials.

Before surgery

Before surgery, imatinib is given for six to twelve months when shrinking the tumor would allow a smaller operation, save the rectal sphincter, or avoid removing a whole organ, with scans every few months to time the surgery at the best response.

How the operation is done

Turn a phone sideways or swipe to see both columns.

Risks and how they are managed

The recovery

After a keyhole wedge resection most patients drink on the first day, eat soft food on the second, and go home after three to five days. Open surgery and bowel resections add a few days. Small meals help. Pain is mild. Walking builds stamina, desk work returns in two to three weeks, and lifting waits six weeks after an open operation. When imatinib follows, it starts once eating is back to normal, within a few weeks of surgery.

How long to stay in Istanbul

Plan for ten to fourteen days after a keyhole wedge, and two to three weeks after a larger open operation.

The timeline also scrolls sideways on small screens.

Published Istanbul packages for stomach surgery list hospital stays from two nights to nine days, the longest for a total gastrectomy, and platform guidance suggests planning 7 to 14 days in Turkey overall. A GIST wedge sits at the shorter end of that range. Pathology arrives before you leave, so the imatinib decision can be made face to face, and fitness to fly is confirmed at the final wound check.

What decides the cost

Keyhole or open surgery, the site, nights in hospital, the mutation test and any imatinib before or after the operation set most of the figure.

Comparable quotes name all of these. Ours comes after the surgical oncology team has seen your scans, biopsy and mutation report, and the review costs nothing.

Arranging the trip

Scans, endoscopy and biopsy reports sent on WhatsApp start the review, and the coordinator who replies follows your case through surgery, the imatinib plan and the scans at home. Our team speaks English, Arabic, French, Russian, Serbian, Romanian and Spanish, with interpreters for other languages. A companion bed in your room lets one relative stay overnight, and the international office books a hotel for anyone else, sends the visa invitation letter ten days before travel and organizes airport transfers. Meals come halal, vegetarian or diabetic, there is a prayer room, and a female physician is available on request. Chemotherapy, radiotherapy and immunotherapy are given on the same site if they are ever needed.

Once you are back home

CT or MRI of the abdomen every three to six months for the first years, and less often later, watches for recurrence in the liver and the lining of the abdomen, and the images can be sent through the coordinator for review. Imatinib needs blood tests. Regular counts and liver tests catch side effects early.

See a doctor the same day for any of these.

• Black stools or vomiting blood
• Fever, or pain that worsens instead of easing
• Repeated vomiting or a swollen abdomen
• Severe diarrhea or swelling while on imatinib

GIST surgery FAQ